Kawasaki disease pathophysiology: Difference between revisions
Line 58: | Line 58: | ||
! style="background:#4479BA; color: #FFFFFF;" |Reference and Year | ! style="background:#4479BA; color: #FFFFFF;" |Reference and Year | ||
|- | |- | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |''FCGR2A'' | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |1q23 | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |GWAS | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |European descent, Taiwanese, Koreans, Han Chinese | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Low-affinity receptor for Fc fragment of IgG; risk allele has lower binding affinity | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Khor et al<ref name="KhorDavila2011">{{cite journal|last1=Khor|first1=C. C.|last2=Davila|first2=S.|last3=Shimizu|first3=C.|last4=Sheng|first4=S.|last5=Matsubara|first5=T.|last6=Suzuki|first6=Y.|last7=Newburger|first7=J. W.|last8=Baker|first8=A.|last9=Burgner|first9=D.|last10=Breunis|first10=W.|last11=Kuijpers|first11=T.|last12=Wright|first12=V. J.|last13=Levin|first13=M.|last14=Hibberd|first14=M. L.|last15=Burns|first15=J. C.|title=Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease|journal=Journal of Medical Genetics|volume=48|issue=7|year=2011|pages=467–472|issn=0022-2593|doi=10.1136/jmg.2010.086611}}</ref>2011 | ||
|- | |- | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |''CASP3'' | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |4q34-35 | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Linkage analysis | ||
Candidate gene study | Candidate gene study | ||
| style="background:#DCDCDC;" |Japanese, Taiwanese, Koreans, Chinese, Euro-Americans | | style="background:#DCDCDC;" |Japanese, Taiwanese, Koreans, Chinese, Euro-Americans | ||
Line 74: | Line 74: | ||
| style="background:#DCDCDC;" |Onouchi et al62 2010 | | style="background:#DCDCDC;" |Onouchi et al62 2010 | ||
|- | |- | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |''HLA''class II | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |6p21.3 | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |GWAS | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Japanese, Taiwanese, Koreans | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Activation marker for immune cells; antigen presentation | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Onouchi et al63 2012 | ||
|- | |- | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |''BLK'' | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |8p23-22 | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |GWAS | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Japanese, Taiwanese, Koreans | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |B-cell receptor signal transduction | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Onouchi et al63 2012 | ||
|- | |- | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |''IPTKC'' | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |19q13.2 | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Linkage analysis | ||
TDT | TDT | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Japanese, Taiwanese, Koreans, Chinese, Euro- Americans | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Negative regulator of calcineurin-NFAT signaling pathway; risk allele increases signaling | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Onouchi et al64 2008 | ||
|- | |- | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |''CD40'' | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |20q12-13.2 | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |GWAS | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Japanese, Taiwanese, Koreans | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Risk alleles associated with increased translation | ||
| style="background:#DCDCDC;" | | style="background:#DCDCDC;" |Onouchi et al63 2012 | ||
|- | |- | ||
| colspan="6" |BLK indicates B-cell lymphoid kinase; CASP3, caspase 3; FCGR, Fcγ receptor; GWAS, genome-wide association study; HLA, human leukocyte antigen; IgG, immunoglobulin G; ITPKC, inositol 1,4,5-trisphosphate kinase-C; KD, Kawasaki disease; NFAT, nuclear factor of activated T cells; and TDT, transmission disequilibrium test. | | colspan="6" |BLK indicates B-cell lymphoid kinase; CASP3, caspase 3; FCGR, Fcγ receptor; GWAS, genome-wide association study; HLA, human leukocyte antigen; IgG, immunoglobulin G; ITPKC, inositol 1,4,5-trisphosphate kinase-C; KD, Kawasaki disease; NFAT, nuclear factor of activated T cells; and TDT, transmission disequilibrium test. |
Revision as of 18:49, 10 April 2018
Kawasaki disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
American Roentgen Ray Society Images of Kawasaki disease pathophysiology |
Risk calculators and risk factors for Kawasaki disease pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The exact pathogenesis of [disease name] is not fully understood.
OR
It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
OR
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
OR
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
OR
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
OR
The progression to [disease name] usually involves the [molecular pathway].
OR
The pathophysiology of [disease/malignancy] depends on the histological subtype.
Pathophysiology
Pathogenesis
- The exact pathogenesis of [disease name] is not fully understood.
OR
- It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
- [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
- Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
- [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
- The progression to [disease name] usually involves the [molecular pathway].
- The pathophysiology of [disease/malignancy] depends on the histological subtype.
Genetics
.
Genes Implicated in Susceptibility to KD With Replication in Independent Cohorts
Adapted from the AHA Scientific Statement on the diagnosis, treatment, and long term management of Kawasaki disease[1] | |||||
Gene | Chromosome Location | Genetic Methods | Validation Populations | Potential Significance | Reference and Year |
---|---|---|---|---|---|
FCGR2A | 1q23 | GWAS | European descent, Taiwanese, Koreans, Han Chinese | Low-affinity receptor for Fc fragment of IgG; risk allele has lower binding affinity | Khor et al[2]2011 |
CASP3 | 4q34-35 | Linkage analysis
Candidate gene study |
Japanese, Taiwanese, Koreans, Chinese, Euro-Americans | Mediates apoptosis in immune cells and cardiomyocytes
Risk allele decreases gene transcription |
Onouchi et al62 2010 |
HLAclass II | 6p21.3 | GWAS | Japanese, Taiwanese, Koreans | Activation marker for immune cells; antigen presentation | Onouchi et al63 2012 |
BLK | 8p23-22 | GWAS | Japanese, Taiwanese, Koreans | B-cell receptor signal transduction | Onouchi et al63 2012 |
IPTKC | 19q13.2 | Linkage analysis
TDT |
Japanese, Taiwanese, Koreans, Chinese, Euro- Americans | Negative regulator of calcineurin-NFAT signaling pathway; risk allele increases signaling | Onouchi et al64 2008 |
CD40 | 20q12-13.2 | GWAS | Japanese, Taiwanese, Koreans | Risk alleles associated with increased translation | Onouchi et al63 2012 |
BLK indicates B-cell lymphoid kinase; CASP3, caspase 3; FCGR, Fcγ receptor; GWAS, genome-wide association study; HLA, human leukocyte antigen; IgG, immunoglobulin G; ITPKC, inositol 1,4,5-trisphosphate kinase-C; KD, Kawasaki disease; NFAT, nuclear factor of activated T cells; and TDT, transmission disequilibrium test. |
Associated Conditions
Gross Pathology
- On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Microscopic Pathology
- On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
References
- ↑ McCrindle, Brian W.; Rowley, Anne H.; Newburger, Jane W.; Burns, Jane C.; Bolger, Anne F.; Gewitz, Michael; Baker, Annette L.; Jackson, Mary Anne; Takahashi, Masato; Shah, Pinak B.; Kobayashi, Tohru; Wu, Mei-Hwan; Saji, Tsutomu T.; Pahl, Elfriede (2017). "Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association". Circulation. 135 (17): e927–e999. doi:10.1161/CIR.0000000000000484. ISSN 0009-7322.
- ↑ Khor, C. C.; Davila, S.; Shimizu, C.; Sheng, S.; Matsubara, T.; Suzuki, Y.; Newburger, J. W.; Baker, A.; Burgner, D.; Breunis, W.; Kuijpers, T.; Wright, V. J.; Levin, M.; Hibberd, M. L.; Burns, J. C. (2011). "Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease". Journal of Medical Genetics. 48 (7): 467–472. doi:10.1136/jmg.2010.086611. ISSN 0022-2593.